Background: Transthoracic FNAC is regarded as the most effective of the cytological methods for diagnosing lung cancer, in particular peripherally-located lesions. Notably, it demonstrates high accuracy in distinguishing between small cell lung carcinoma and non-small cell lung carcinoma, a clinically important differentiation. Results: In the present study out of 31 cases, lung carcinoma was diagnosed in 28 cases (90.32 %). Out of 28 patients, 27 cases (96.42 %) were diagnosed to have Non-small cell lung carcinoma category (NSCLC) which was further classified into Adenocarcinoma 9 cases (29.63%) , Squamous cell carcinoma 8 cases (33.34%), Large Cell Carcinoma 3 cases (11.11%), Metastatic Carcinoma 2 cases (7.4%) and 5 cases (18.52 %) were unclassified. While only 1 case (3.58%) of Small Cell lung carcinoma category (SCLC) was diagnosed. In 2 cases inflammatory lesions were found and 1 case was inadequate for assessment. The diagnostic accuracy was 95%, sensitivity 96.55% and specificity 100% considering cytological criteria as the standard. Conclusion: We concluded that Transthoracic Fine Needle aspiration Cytology with Ultrasound guided procedure is simple, safe & cost effective diagnostic technique in Bronchiogenic Carcinoma, with early diagnosis and minimal complications.
Introduction
Bronchiogenic carcinoma is the most common malignancy in the world, accounting for 7% of all deaths in men and women. It is the leading cause of death in industrialised countries and also rising at alarming rates in developing countries. [1] The diagnosis of Bronchiogenic carcinoma by cytologic methods is of historic interest because they were early manifestations of malignancy as diagnosed by examining the exfoliated cells. Donne and Walsh noted that exfoliated respiratory cells including cancer cells occurred in sputum as early as 1845. The first major series in patients in which the examination of sputum led to a diagnosis of lung cancer was by Hamplen in 1919. [2] After several years of quiescence; pulmonary cytology enjoyed a period of rapid development in the 1970s and 1980s. During this time, fine needle aspiration was validated as an alternative to open lung biopsy and technical advance in radiologic technique as well as improvement in the design of bronchoscopes permitted the imaging of small lesions and guidance of fine needle. [3] Fine-needle aspiration cytology (FNAC) is a wellestablished method of diagnosing both neoplastic and inflammatory conditions of the lungs. [4] Together with other cytological methods of diagnosis of lung diseases, it has resulted in a decrease in the performance of procedures that are more invasive in nature. Transthoracic FNAC is regarded as the most effective of the cytological methods for diagnosing lung cancer, in particular peripherally-located lesions. It demonstrates high accuracy in distinguishing between small cell lung carcinoma and non-small cell lung carcinoma, a clinically important differentiation. It is cheap, can be repeated and the complication rate is low. [5] Thus this study was carried out to investigate the diagnostic value & safety of Ultra sound guided Transthoracic Lung Fine Needle Aspiration Cytology examination in Bronchogenic Carcinoma.
Materials and Methods
The present study was conducted at Pathology Department of S.S.G Hospital and Medical College, Baroda after getting approval from Ethical Committee. A lumbar puncture needle of gauge 20 was used to collect the desired material and was passed through the marked site then Ultrasound machine probe confirmed that the needle was in the lesion and then the trocar was removed and 10 cc disposable syringe was attached and desired material was obtained by Fine Needle Aspiration Cytology procedure. Smear was made and material was stained with Hematoxylin & Eosin, Giemsa and Papanicoloua stain.
Results
In this study, we included 31 patients with suspected thoracic mass lesions who were hospitalized and examined in our hospital between December 2011 to November 2013. Among the total cases, male to female ratio was found to be 4:1 and mean age of the patients was 55.8±12.34 years. Maximum number of cases 18 (59.06 %) were in age group of 50-69 years. Non-Small Cell Lung Carcinoma (NSCLC) was found to be more common than Small Cell lung Carcinoma (SCLC). There were 27 (87.1%) cases of NSCLC and only 1 (3.22%) case of SCLC. General demographic findings of the study are summarised in Table 1. Among the Non-small cell carcinoma category, Squamous cell carcinoma was found in 8 out of 27 cases, Adenocarcinoma in 9 cases, Large cell carcinoma in 3 cases, metastatic carcinoma in 2 cases and 5 cases were unclassified (Diagram 1).There was increased prevalence of Squamous cell carcinoma in males while Adenocarcinoma was found more common in females. Majority of the cases in this study were 25 males (n=25 %) and 6 cases were females (19.35 %). The mean age of the patients was 55.8±12.34 years. These results are similar to findings of other studies. Hakan Solak et al [8] conducted a study of 102 patients, 86 of them were male, 16 of them were female, and their mean age was 50±6.5 years. Md Quamrul Hassan [1] also found similar results where average age of the patients was 60.14 years and male to female ratio was 5.5:1. Females were less because bronchiogenic carcinoma is less in females due to less smoking.
In this study, among 27 cases of Non-Small Cell Lung Carcinoma, Squamous cell carcinoma was found in 8 cases (29.63%). Adenocarcinoma was seen in 9 cases (33.34 %) and Large cell carcinoma was seen in only 3 case (11.11 %), Metastatic carcinoma in 2 cases (7.4%).
The prevalence of squamous cell carcinoma and adenocarcinoma were similar (22%) in the study by Singh et al [9] but our results showed higher prevalence of adenocarcinoma which is similar to the findings by K B Tan et al. [5] Where they found Adenocarcinoma 37 (49.4%), Squamous cell carcinoma 12 (16.0%), Large cell lung carcinoma 2 (2.7%), Metastatic adenocarcinoma 3 (4.0%). In various literatures it is recorded that in the diagnosis of lung cancer, the sensitivity of Transthoracic FNAC technique is 80-95%, and the specificity is 95-100%. In our study, the sensitivity was found to be 96.55%, the specificity 100% and, which is similar to the other studies by Singh et al [9] , Yaman et al [10] , Samurkaboulu B et al [11] and Zhan et al [12] .
In the present study, the only complication developed was Pneumothorax, noted in only one case (3.1%). Pneumothorax was significantly lower than the 42.7%, 29%, 20.9% and 11.8% seen in the studies conducted by Vansonnenberg et al [13] , Stanley et al [14] Santambrogio et al [15] and Singh et al [9] respectively. This variability may be due to the differences in the definitions of significant complications and in the stringency in which they are reported. It was comparable similar to the 3.1%, 2.7% and 1.1% of Gouliamos et al [16] and Gupta et al [17] .
Thus in this study Ultrasound Guided Transthoracic FNAC was done for the diagnosis of Bronchiogenic Carcinoma and was found to be an effective, safe and speedy and relatively cheap method and only complication developed was Pneumothorax. This study included 31 cases, though a large scale prospective or case controlled type study should be done to establish a statistical significance and correlation.
Conclusion
Transthoracic FNAC with Ultrasound guided procedure is an accurate and safe method for the diagnosis of localised lung lesions. Cytologically it can accurately distinguish SCLC from NSCLC because these two categories were the most relevant for directing therapy. It can be easily performed and is well-tolerated method with high diagnostic accuracy and low complication rate, and thus, obviates more invasive diagnostic procedures.
